| OptiType: precision HLA typing from next-generation sequencing data A Szolek, B Schubert, C Mohr, M Sturm, M Feldhahn, O Kohlbacher Bioinformatics 30 (23), 3310-3316, 2014 | 660 | 2014 |
| Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma MW Löffler, C Mohr, L Bichmann, LK Freudenmann, M Walzer, ... Genome medicine 11, 1-16, 2019 | 112 | 2019 |
| Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient MW Löffler, PA Chandran, K Laske, C Schroeder, I Bonzheim, M Walzer, ... Journal of hepatology 65 (4), 849-855, 2016 | 86 | 2016 |
| MHCquant: automated and reproducible data analysis for immunopeptidomics L Bichmann, A Nelde, M Ghosh, L Heumos, C Mohr, A Peltzer, ... Journal of proteome research 18 (11), 3876-3884, 2019 | 40 | 2019 |
| FRED 2: an immunoinformatics framework for Python B Schubert, M Walzer, HP Brachvogel, A Szolek, C Mohr, O Kohlbacher Bioinformatics 32 (13), 2044-2046, 2016 | 37 | 2016 |
| Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy F Blaeschke, MC Paul, MU Schuhmann, A Rabsteyn, C Schroeder, ... Cytotherapy 21 (9), 973-986, 2019 | 30 | 2019 |
| qPortal: A platform for data-driven biomedical research C Mohr, A Friedrich, D Wojnar, E Kenar, AC Polatkan, MC Codrea, ... PLoS One 13 (1), e0191603, 2018 | 27 | 2018 |
| ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification L Schneider, T Kehl, K Thedinga, NL Grammes, C Backes, C Mohr, ... Bioinformatics 35 (24), 5171-5181, 2019 | 19 | 2019 |
| ImmunoNodes–graphical development of complex immunoinformatics workflows B Schubert, L de la Garza, C Mohr, M Walzer, O Kohlbacher BMC bioinformatics 18, 1-7, 2017 | 12 | 2017 |
| Ws-pgrade/guse-based science gateways in teaching SD Olabarriaga, A Benabdelkader, MWA Caan, MM Jaghoori, J Krüger, ... Science Gateways for Distributed Computing Infrastructures: Development …, 2014 | 3 | 2014 |
| Bringing the Algorithms to the Data--Secure Distributed Medical Analytics using the Personal Health Train (PHT-meDIC) MAB Herr, M Graf, P Placzek, F König, F Bötte, T Stickel, D Hieber, ... arXiv preprint arXiv:2212.03481, 2022 | 2 | 2022 |
| iVacALL: utilizing next-generation sequencing for the establishment of an individual peptide vaccination approach for paediatric acute lymphoblastic leukaemia C Kyzirakos, U Pflueckhahn, M Sturm, C Schroeder, P Bauer, M Walter, ... Bone Marrow Transplant. 48 (3), 2013 | 2 | 2013 |
| Bringing the Algorithms to the Data--Secure Distributed Medical Analytics using the Personal Health Train (PHT-meDIC) M de Arruda Botelho Herr, M Graf, P Placzek, F König, F Bötte, T Stickel, ... arXiv e-prints, arXiv: 2212.03481, 2022 | 1 | 2022 |
| Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients A Rabsteyn, C Kyzirakos, C Schroeder, M Sturm, C Mohr, J Matthes, ... Cancer Immunology Research 7 (2_Supplement), B124-B124, 2019 | 1 | 2019 |
| Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients A Rabsteyn, C Kyzirakos, C Schroeder, M Sturm, C Mohr, J Matthes, ... CANCER IMMUNOLOGY RESEARCH 7 (2), 2019 | 1 | 2019 |
| IVAC-all-1: interim analysis of a phase I/II clinical study on personalized peptide vaccination based on patient-individual tumor-specific variants in relapsed pediatric acute … A Rabsteyn, C Mohr, O Witt, R Meisel, C Chen-Santel, T Feuchtinger, ... Bone Marrow Transplantation 54, 2019 | 1 | 2019 |
| Abstract CT057: Phase I trial to evaluate the feasibility and safety of an individualized peptide vaccine of unmodified cancer antigens: PepIVAC-01 S Haen, MW Löffler, O Kohlbacher, S Nahnsen, C Mohr, M Stieglbaueren, ... Cancer Research 78 (13_Supplement), CT057-CT057, 2018 | 1 | 2018 |
| qPortal–A science gateway for biomedical applications C Mohr, A Friedrich, D Wojnar, E Kenar, AC Polatkan, MC Codrea, ... PeerJ PrePrints, 2017 | 1 | 2017 |
| Optimized neoantigen selection based on tumor exome data C Kyzirakos, C Mohr, S Armeanu-Ebinger, M Feldhahn, D Hadaschik, ... Annals of Oncology 27, vi375, 2016 | 1 | 2016 |
| Personalized peptide-vaccination for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants (iVacALL) P Lang, A Rabsteyn, C Kyzirakos, C Schroeder, M Sturm, C Mohr, ... ONCOLOGY RESEARCH AND TREATMENT 39, 125-125, 2016 | 1 | 2016 |
Alexander PeltzerPrincipal Scientist Clinical Bioinformatics Oncology, Boehringer IngelheimVerified email at boehringer-ingelheim.com
